Telix Pharmaceuticals reported strong H1 2025 results, with a 63% year-over-year revenue increase to $390.4 million, keeping the company...

Ascentage Pharma’s H1 2025 results reveal a company navigating a complex transition, marked by soaring sales of its flagship...

Novonesis, a key player in the biosolutions market, reported robust first-half 2025 results, posting 9% organic sales growth and...

Nicox’s positive Phase 3 DENALI trial results for NCX 470 in glaucoma patients reinforce the drug’s potential to disrupt...

Ascentage Pharma’s H1 2025 results reveal a company navigating a complex landscape of commercial growth and pipeline advancement, underscored...

GenXTraits and Mendel Biotechnology have formed a strategic partnership focused on developing next-generation crop traits, with Mendel taking a...

Novabay Pharmaceuticals has secured a $6 million investment from private investor David E. Lazar, marking a pivotal shift for...

Novabay Pharmaceuticals, securing a $6 million investment from private investor David E. Lazar, has opted for a strategic pivot...

Tevogen Bio Secures $50 Million Financing After Debt Elimination Tevogen Bio, a clinical-stage biotech focused on off-the-shelf T-cell therapies,...

Opthea Limited has reached a settlement with its development funding agreement (DFA) investors, staving off potential insolvency and charting...